Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Natalia Alonso Vence"'
Autor:
Adrián Mosquera Orgueira, José Ángel Díaz Arias, Miguel Cid López, Andrés Peleteiro Raíndo, Beatriz Antelo Rodríguez, Carlos Aliste Santos, Natalia Alonso Vence, Ángeles Bendaña López, Aitor Abuín Blanco, Laura Bao Pérez, Marta Sonia González Pérez, Manuel Mateo Pérez Encinas, Máximo Francisco Fraga Rodríguez, José Luis Bello López
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Thirty to forty percent of patients with Diffuse Large B-cell Lymphoma (DLBCL) have an adverse clinical evolution. The increased understanding of DLBCL biology has shed light on the clinical evolution of this pathology, leading to
Externí odkaz:
https://doaj.org/article/47def9812b5e4561b9a2ffba19e04710
Autor:
Adrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, Beatriz Antelo Rodríguez, José Ángel Díaz Arias, Roi Ferreiro Ferro, Natalia Alonso Vence, Ángeles Bendaña López, Aitor Abuín Blanco, Laura Bao Pérez, Paula Melero Valentín, Marta Sonia González Pérez, Claudio Cerchione, Giovanni Martinelli, Pau Montesinos Fernández, Manuel Mateo Pérez Encinas, José Luis Bello López
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Externí odkaz:
https://doaj.org/article/7621093bf9e0435ab51db257b2df8022
Autor:
Adrián Mosquera Orgueira, Beatriz Antelo Rodríguez, Natalia Alonso Vence, José Ángel Díaz Arias, Nicolás Díaz Varela, Manuel Mateo Pérez Encinas, Catarina Allegue Toscano, Elena María Goiricelaya Seco, Ángel Carracedo Álvarez, José Luis Bello López
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Chronic Lymphocytic Leukemia (CLL) is the most frequent lymphoproliferative disorder in western countries and is characterized by a remarkable clinical heterogeneity. During the last decade, multiple genomic studies have identifie
Externí odkaz:
https://doaj.org/article/60df5c8d5999426b86a2243b980611fb
Autor:
Adrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, José Ángel Díaz Arias, Marta Sonia González Pérez, Beatriz Antelo Rodríguez, Natalia Alonso Vence, Laura Bao Pérez, Roi Ferreiro Ferro, Manuel Albors Ferreiro, Aitor Abuín Blanco, Emilia Fontanes Trabazo, Claudio Cerchione, Giovanni Martinnelli, Pau Montesinos Fernández, Manuel Mateo Pérez Encinas, José Luis Bello López
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Acute Myeloid Leukemia (AML) is a heterogeneous neoplasm characterized by cytogenetic and molecular alterations that drive patient prognosis. Currently established risk stratification guidelines show a moderate predictive accuracy, and newer tools th
Externí odkaz:
https://doaj.org/article/0c2126a43e2b4b08bd36aea5a3a142eb
Autor:
Adrián Mosquera Orgueira, Roi Ferreiro Ferro, José Ángel Díaz Arias, Carlos Aliste Santos, Beatriz Antelo Rodríguez, Laura Bao Pérez, Natalia Alonso Vence, Ággeles Bendaña López, Aitor Abuin Blanco, Paula Melero Valentín, And Res Peleteiro Raindo, Miguel Cid López, Manuel Mateo Pérez Encinas, Marta Sonia González Pérez, Máximo Francisco Fraga Rodríguez, José Luis Bello López
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0248886 (2021)
B-cell lymphoproliferative disorders exhibit a diverse spectrum of diagnostic entities with heterogeneous behaviour. Multiple efforts have focused on the determination of the genomic drivers of B-cell lymphoma subtypes. In the meantime, the aggregati
Externí odkaz:
https://doaj.org/article/754ac779e90d4b05b34d220930ad3e5d
Autor:
Adrián Mosquera Orgueira, Andrés Peleteiro Raíndo, Miguel Cid López, Beatriz Antelo Rodríguez, José Ángel Díaz Arias, Roi Ferreiro Ferro, Natalia Alonso Vence, Ángeles Bendaña López, Aitor Abuín Blanco, Laura Bao Pérez, Paula Melero Valentín, Marta Sonia González Pérez, Claudio Cerchione, Giovanni Martinelli, Pau Montesinos Fernández, Manuel Mateo Pérez Encinas, José Luis Bello López
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247093 (2021)
BackgroundFLT3 mutation is present in 25-30% of all acute myeloid leukemias (AML), and it is associated with adverse outcome. FLT3 inhibitors have shown improved survival results in AML both as upfront treatment and in relapsed/refractory disease. Cu
Externí odkaz:
https://doaj.org/article/cbe01aa7d0234032abc58f5a46490841
Autor:
Adrián Mosquera Orgueira, Beatriz Antelo Rodríguez, Natalia Alonso Vence, Ángeles Bendaña López, José Ángel Díaz Arias, Nicolás Díaz Varela, Marta Sonia González Pérez, Manuel Mateo Pérez Encinas, José Luis Bello López
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Chronic lymphocytic leukemia (CLL) is the most frequent lymphoproliferative syndrome in western countries. CLL evolution is frequently indolent, and treatment is mostly reserved for those patients with signs or symptoms of disease progression. In thi
Externí odkaz:
https://doaj.org/article/3ffc12193d7347cfb246f3b75993dac0
Autor:
Ángel Carracedo Álvarez, Nicolás Díaz Varela, Beatriz Antelo Rodríguez, Adrián Mosquera Orgueira, Catarina Allegue Toscano, Elena María Goiricelaya Seco, José Ángel Díaz Arias, Manuel Mateo Pérez Encinas, Natalia Alonso Vence, José Luis Bello López
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
BMC Cancer
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
BMC Cancer
Background Chronic Lymphocytic Leukemia (CLL) is the most frequent lymphoproliferative disorder in western countries and is characterized by a remarkable clinical heterogeneity. During the last decade, multiple genomic studies have identified a myria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad40c358c86bc6f92695770922ee8378
http://link.springer.com/article/10.1186/s12885-019-5628-y
http://link.springer.com/article/10.1186/s12885-019-5628-y
Autor:
Jose Luis Bello Lopez, Adrian Mosquera Orgueira, Roi Ferreiro Ferro, Miguel Cid López, José Ángel Díaz Arias, Beatriz Antelo Rodríguez, Laura Bao Pérez, Carlos Aliste Santos, Manuel Mateo Pérez Encinas, Natalia Alonso Vence, Ángeles Bendaña López, Maximo Francisco Fraga Martinez, Aitor Abuin Blanco, Paula Melero Valentín, Andrés Peleteiro Raíndo, Marta Sonia González Pérez
Growing evidence has revealed the implication of germline variation in cancer predisposition and prognostication. Here, we describe an analysis of putatively disruptive rare variants across the genomes of 726 patients with B-cell lymphoid neoplasms.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adac61c885a683d4b706fbfc63db51c9
Autor:
Aitor Abuin Blanco, Ángeles Bendaña López, Adrián Mosquera Orgueira, Giovanni Martinelli, Andrés Peleteiro Raíndo, Laura Bao Pérez, Natalia Alonso Vence, José Luis Bello López, Marta Sonia González Pérez, Roi Ferreiro Ferro, Miguel Cid López, José Ángel Díaz Arias, Pau Montesinos Fernández, Claudio Cerchione, Paula Melero Valentín, Beatriz Antelo Rodríguez, Manuel Mateo Pérez Encinas
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0247093 (2021)
PLoS ONE
PLoS ONE
Background FLT3 mutation is present in 25–30% of all acute myeloid leukemias (AML), and it is associated with adverse outcome. FLT3 inhibitors have shown improved survival results in AML both as upfront treatment and in relapsed/refractory disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993487ad74dff072d109b05ebeaad2fc
https://doaj.org/article/cbe01aa7d0234032abc58f5a46490841
https://doaj.org/article/cbe01aa7d0234032abc58f5a46490841